Filing Flows › Comparisons › NRC vs MXCT
NRC Health vs Maxcyte: NRC and MXCT compared
NRC Health is the larger company: $38.4M of revenue in its latest quarter (Q3 2026) against $7.3M for Maxcyte (Q2 2026). NRC Health is growing faster (+11% against -14% a year earlier). NRC Health is more profitable, with an operating margin of 23.2% against -140.7%.
Where the money goes: NRC and MXCT
NRC Health (NRC) · Q3 2026
NRC Health, Q3 2026: revenue $38.4M (+11% year over year), operating margin 23.2%, net earnings $4.7M, operating cash flow $8.0M. The chart follows the revenue to costs, profit and cash.
Maxcyte (MXCT) · Q2 2026
Maxcyte, Q2 2026: revenue $7.3M (-14% year over year), operating margin -140.7%, net loss $8.9M, operating cash flow −$4.7M. The chart follows the revenue to costs, profit and cash.
| NRC Health (NRC) | Maxcyte (MXCT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $38.4M | $7.3M |
| Revenue growth, Y/Y | +11% | -14% |
| Operating margin | 23.2% | -140.7% |
| Net earnings | $4.7M | −$8.9M |
| Net margin | 12.3% | -122.0% |
| Operating cash flow | $8.0M | −$4.7M |
| Free cash flow | $7.0M | — |
Where the revenue comes from
Maxcyte
- Product sales: $4.1M (56%)
- Licenses: $2.6M (36%)
- Assay and other service revenue: $583K (8%)
Questions
Which is bigger, NRC Health or Maxcyte?
NRC Health is the larger company: $38.4M of revenue in its latest quarter (Q3 2026) against $7.3M for Maxcyte (Q2 2026).
Is NRC Health or Maxcyte growing faster?
NRC Health is growing faster (+11% against -14% a year earlier).
Which is more profitable, NRC Health or Maxcyte?
NRC Health is more profitable, with an operating margin of 23.2% against -140.7%.
More: NRC Health earnings · how NRC Health makes money · Maxcyte earnings · how Maxcyte makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.